• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

Minimed 670g System To Be Made Available In Europe

DCUK NewsBot

DCUK NewsBot

Well-Known Member
Messages
4,059
Medtronic's MiniMed 670G has become the world’s first "hybrid closed-loop system" to secure the CE Mark, making the device available for sale in the European Union. By receiving the CE Mark the MiniMed 670G meets the health, safety, and environmental protection standards for products sold within Europe. It is now expected the device will be available in select European countries towards the end of 2018. The MiniMed 670G, developed to make the lives of people with type 1 diabetes easier, was in 2016 approved for use in the US by the Food and Drug Administration (FDA) and launched in 2017. The system combines an automated insulin pump with a continuous glucose monitor, and self-adjusts blood sugar levels and delivers basal insulin when needed. The device uses a sensor called Guardian 3, which is inserted under the skin and thought to be 80% smaller than its predecessor, the Enlite. It also lasts an entire week, allowing for prolonged measurements of blood sugar levels. Dr Pratik Choudhary, senior lecturer and consultant in diabetes at King’s College London, said: "We have seen that this innovation offers great promise for better glucose control and improved quality of life for those living with type 1 diabetes. "The ability of the MiniMed 670G system to stabilise glucose levels automatically is an important advancement, and I look forward to introducing it to my patients in Europe." Alejandro Galindo, president of the Advanced Insulin Management division within the Diabetes Group at Medtronic, said: "The MiniMed 670G system advances our ability to automatically suspend and resume insulin delivery to the next level by automating self-adjusting basal insulin delivery every five minutes based on sensor glucose values - providing the most advanced algorithm available to deliver leading clinical outcomes." The system has been through a series of vigorous tests to ensure it is safe for people to use. Earlier this year the device was shown to help children better manage their type 1 diabetes without experiencing severe hypos or diabetic ketoacidosis.

Continue reading...
 
That is great news. I just wished the Australian Government and Medtronic would follow suit here in Australia with making this pump available here.
Cost and affordability are another factors with using such a pump as well as knowing how accurate the Guardian system is compared to the Enlite and Dexcom equivalents.
And as an adult I would feel miffed if there was not a discount on Medtronic's accessory, the cute soft toy lion to carry such a pump.
 
I’ve heard that if you like to run with conservative numbers, it’s okay. Medtronic’s CGM is still only as-good-as Medtronic’s CGM.
 
Jollymon said:
I’ve heard that if you like to run with conservative numbers, it’s okay. Medtronic’s CGM is still only as-good-as Medtronic’s CGM.
Click to expand...
Thank you @Jollymon , do you know how Medtronic's CGM compares to Dexcom. The threads/post suggest Dexcom is superior but the sample size of comparison is perhaps not large enough to be definitive.?
 
The MAR data on dexcom G6 is supposed to be better. But even G5 MAR data is supposed to be better than Medtronic’s. But Medtronic is the 1st packaged closed loop system, so people will want it because it’s not a DIY system.

Libre’s MAR data for accuracy is better than Medtronic’s, but again it’s not a packaged closed loop system.

I don’t trust CGM, so I’m not excited for it. But the system is out there.
 
Thank you @Jollymon,
Like all or most systems of measurement you either accept the limitations and live with that and hope it is worth the risk or wait for something better. At the cost of CGM and with its variability I too am most hesitant to embrace it.
The 'radar' system mentioned in the news thread is interesting but at 85% accuracy has a way to go yet ! And maybe there needs to be more than one site to check BSLs from in order to increase accuracy of any given system. A system that accurately measures blood sugar from the portal vein would be awesome, too !!
 
If you’ve ever experienced a cgm sensor going unreliably looney, you’d understand my concern. But people want easy, and managing this condition isn’t easy. Some never understand it. This closed loop pump will sell well because people want easy.

The system will only allow someone to shoot for ave bs of around 120 mg/dL, or a 6.7. No better than that. I’ve heard of some using the prime function to do better, but they’re priming all the time. The system in closed loop won’t let you dose.

I would agree that a sensor testing actual sugar in blood would be better. The body runs on blood and blood sugar, not interstitial fluid. Interstitial fluid is a secondary thing.

I’d sign up for an implanted sensor to test blood sugar. But do you realize what it would do to the entire test strip market? We could test blood sugar without an expendable- the test strip would be obsolete. That whole cash cow segment would be destroyed and that’s a big money maker. This is the kind of stuff that drives diabetes conspiracy theory.
 
Jollymon said:
If you’ve ever experienced a cgm sensor going unreliably looney, you’d understand my concern. But people want easy, and managing this condition isn’t easy. Some never understand it. This closed loop pump will sell well because people want easy.

The system will only allow someone to shoot for ave bs of around 120 mg/dL, or a 6.7. No better than that. I’ve heard of some using the prime function to do better, but they’re priming all the time. The system in closed loop won’t let you dose.

I would agree that a sensor testing actual sugar in blood would be better. The body runs on blood and blood sugar, not interstitial fluid. Interstitial fluid is a secondary thing.

I’d sign up for an implanted sensor to test blood sugar. But do you realize what it would do to the entire test strip market? We could test blood sugar without an expendable- the test strip would be obsolete. That whole cash cow segment would be destroyed and that’s a big money maker. This is the kind of stuff that drives diabetes conspiracy theory.
Click to expand...

Hi @Jollymon, I could not agree more. Perhaps the restrictions on T2D testing plus the need for occasional meter use to check the CGM sensors will allow a modified market for meters/strips to continue. But big Pharma will always err on the side of profit.
Of course, competing against the human body's development of blood glucose over thousands of years is a big ask for the purest of researchers.
And i equate (improperly I am sure) the closed loop to autopilot, great for smooth, no hands, no thinking required flights (maybe) but not good for turbulence, flexibility, experimentation and innovation etc. It ain't human enough and big Pharma do not get it, or do not wish to - every system needs to incorporate an override function!!
If only dogs could adapt their sensory functions to smell an individual's human blood sugar levels and report them !!
 
But dogs can smell blood sugar levels-those animals just don’t know how to effectively communicate back to us what they are :bored:
 
kitedoc said:
Perhaps we would have better luck with dolphins !!??
Click to expand...
That reminds of a story. A researcher of orcas was diving with them and she is actually a type 1 diabetic (how she managed to get a diver's license who knows ??) According to her, with some observations from other divers but who were some distance away, she lost consciousness underwater. Two orcas lifted her to the surface where she recovered. It was likely that she had suffered a hypo underwater !
 
Back
Top